This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. India’s pharmaceutical industry is a global powerhouse. The solution set for this is clear and available.
Those taking Ozempic also had 32% lower odds of needing to be readmitted to the hospital, with no increase in risk for postoperative complications. Novo Holdings, the controlling shareholder of Novo Nordisk, plans to invest about $35 billion by 2030 , Reuters writes.
The data will serve as a foundation for cutting-edge research and will catalyse innovations in areas such as mRNA-based vaccines, protein manufacturing, and genetic disorder treatments. The Minister also pointed out that India is the largest vaccine producer in the world and the third-largest startup ecosystem.
This provides an opportunity to directly engage with high-ranking pharma executives, buyers, procurement managers, contract manufacturers, hospital administrators, as well as representatives from national and state regulatory boards and policymakers.
The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. According to the World Health Organization, the world will need more than 40 million new doctors, nurses, frontline healthcare workers, and various other healthcare professionals by 2030.
Lifted by increased interest after the onset of the Covid-19 pandemic, the sector is expected to balloon to US$853 billion by 2030. Since the onset of the pandemic, the government has invested more than C$1.2bn in 28 Covid-19 domestic biomanufacturing, vaccine and therapeutics projects.
Initiatives such as Ayushmaan Bharat Digital Mission (“ADBDM”), CoWIN (a digital vaccine delivery platform), health registry, and telemedicine, highlight the government’s strong emphasis on digitisation of health in India. million nurses/midwives in the total stock by 2030. A recent WHO report estimated a shortage of about 1.8
By 2030, it strives to “free more than one billion people who currently require interventions against neglected tropical diseases.”. In Muratov’s opinion, this was reflective of a wider pattern seen in almost any other field of research, which could now change with the development of Covid-19 vaccines and antivirals.
On December 20, 2022, the World Health Organization (WHO) updated its recommendations for cervical cancer vaccines in a bid to boost vaccination coverage. Several cervical cancer vaccines are currently approved, including Merck’s nonavalent vaccine Gardasil 9 and GSK’s bivalent vaccine Cervarix.
It is the year 2030. It could be that you are lucky, and there is already a cancer vaccine on the market that you will get priority for. Alternatively, there are vaccines ready to enter decentralised third-phase clinical trials, so you can enrol quickly. It is the year 2030.
It is not the same to live in the Pyrenees, said the MEP, as it is to live in Madrid or Barcelona, where the big hospitals are. This includes vaccines which prevent diseases, such as for HPV papilloma, which is already part of the European plan. With 90% of adolescents that should be vaccinated by 2030, Luppi deems it an opportunity.
Thousands of people in the UK will be screened for hepatitis C virus in a new pilot aimed at expanding use of antiviral therapies to eradicate the infectious – and eliminate it altogether by 2030. ” Image source: University College London Hospitals NHS Foundation Trust.
of the newly combined company The combined companies’ focus is to advance Elicio’s lymph node-targeting amphiphile technology to develop immunotherapies & also focus on ELI-002, a therapeutic cancer vaccine targeting mKRAS-driven tumors is currently being evaluated in the P-I trial (AMPLIFY-201) for PDAC and CRC.
One threat to the new drug is Pfizer’s RSV vaccine, intended for administration to expectant mothers, which is due to generate phase 3 results in this setting in the coming months. Pfizer has already reported late-stage data showing the vaccine is effective in older adults.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content